Dermatology Times

AUGUST 2, 2024

Michele Ramien, MD, discusses biologic therapies for pediatric dermatology, focusing on their impact on vaccines, managing side effects, and tailoring treatment.

Therapy 74

Therapy Dermatology Management Treatments 74

Dermatology Times

DECEMBER 26, 2024

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in aesthetic/cosmetic dermatology this year.

Dermatology 78

Dermatology Therapy 78

The Dermatology Digest

FEBRUARY 21, 2025

After undergoing months of treatment with traditional therapies for erythroderma, which included the steroid prednisone, anti-itch creams, and immunosuppressive drugs, the patient experienced little relief. These cytokines appeared to be the key cytokines in defining the disease. and Akiko K.

Therapy 69

Therapy Dermatology Medical Exfoliation 69

Dermatology Times

JULY 14, 2024

Browning discusses his participation in an SPD 2024 panel discussion, the future of pediatric dermatology, and more.

Dermatology 78

Dermatology Medical Therapy 78

The Dermatology Digest

JANUARY 20, 2025

The test result, in which patients are stratified into a Class 1 (low), Class 2A (higher) or Class 2B (highest) risk category, predicts individual metastatic risk to inform risk-appropriate management and guide decision-making regarding the use of adjuvant radiation therapy.

Hospital 74

Hospital Networking Management Dermatology 74

The Dermatology Digest

SEPTEMBER 22, 2024

Researchers from the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine scored a five-year, $2.2 With no animal models, researchers can’t recreate HS and test different therapies. The research study is led by: Marjana Tomic-Canic, PhD, the William H. Eaglstein, M.D.,

Dermatology 74

Dermatology Surgery Therapy 74

The Dermatology Digest

AUGUST 29, 2024

Food and Drug Administration (FDA)-approved therapies for scarring alopecia, and existing treatments are often ineffective, which is why many patients turn to complementary and alternative therapies. Honey may be a safe and cost-effective adjuvant therapy for folliculitis decalvans, but larger controlled studies are needed.

Scarring 74

Scarring Therapy Extractions Medical 74

Dermatology Times

FEBRUARY 17, 2024

Susan Taylor, MD, provided insight into epidemiology, patient quality of life, clinical presentation, therapies, and more at Masterclasses in Dermatology.

Therapy 74

Therapy Clinic Dermatology 74

The Dermatology Digest

MAY 29, 2024

Researchers led by Adam Friedman , MD, Professor and Chair of Dermatology at the George Washington (GW) University School of Medicine and Health Sciences in Washington, DC, and Sapana Desai, dermatology research fellow at GW, evaluated the available data to highlight the benefits of using isotretinoin for rosacea. .

Rosacea 74

Rosacea Therapy Dermatology Management 74

The Dermatology Digest

NOVEMBER 20, 2024

The post Expert Reaction: FDA Accepts Dupilumab sBLA for CSU appeared first on The Dermatology Digest.

Clinic 69

Clinic Therapy Dermatology 69

The Dermatology Digest

FEBRUARY 20, 2024

Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors. ” Peter Marks, MD, PhD, Director of the FDA’s CBER With TIL therapy, melanoma tumors are surgically removed and then sent to a manufacturing facility where tumor-infiltrating lymphocytes are removed and grown to billions. .

Therapy 72

Therapy Clinic Surgery Innovations 72

Dermatology Times

JULY 14, 2024

Andrea Zaenglein, MD, discussed the role of patient counseling and addressing "hormone phobia" in young patients treated with hormonal therapies for acne in her SPD 2024 session.

Acne Care 81

Acne Care Therapy 81

Dermatology Times

JUNE 1, 2024

Ben Lockshin, MD, FAAD, delves into the new generation of oral psoriasis therapies to enhance patient quality of life.

Therapy 78

Therapy 78

The Dermatology Digest

FEBRUARY 5, 2025

DEBRA Research GmbH, a non-profit organization focused on advancing research, advocacy, and support for those affected by Epidermolysis Bullosa (EB), and LEO Pharma are partnering to accelerate the development of new therapies for EB. There are currently no approved treatment options for EB. Together, we can do so much more.

Partnerships 65

Partnerships Treatments Pharmaceutical Office 65

The Dermatology Digest

APRIL 9, 2025

The post Now Available: National Rosacea Societys Updated Rosacea Treatment Algorithms appeared first on The Dermatology Digest. According to the updated standard classification of rosacea, the presence of persistent facial redness or, less commonly, phymatous changes is considered diagnostic of the disorder.

Rosacea 63

Rosacea Treatments Management Facials 63

Dermatology Times

MARCH 11, 2024

Lio spoke with Dermatology Times to discuss his sessions at AAD 2024, including addressing systemic malignancies with alternative or adjunctive therapies and the importance of minimizing pain in dermatology procedures.

Therapy 73

Therapy Dermatology 73

Dermatology Times

FEBRUARY 18, 2024

A poster presentation explored the transformative impact of integrating clinical pharmacists into an outpatient dermatology clinic, emphasizing collaborative efforts to enhance patient care and improve outcomes in biologic therapy.

Clinic 74

Clinic Dermatology Therapy 74

The Dermatology Digest

APRIL 21, 2025

Vitiligo treatment should focus on repigmentation or stabilizing progression, rather than on depigmentation, according to n ew Canadian Consensus Guidelines for the Management of Vitiligo in Dermatology and Therapy.

Management 36

Management Therapy Tools Clinic 36

The Dermatology Digest

JULY 24, 2024

Stelara is a currently approved treatment for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic arthritis, moderately to severely active Crohn’s, and moderately to severely active ulcerative colitis.

Dermatology 78

Dermatology Sales Marketing Safety 78

Lipgloss and Aftershave

NOVEMBER 1, 2024

Krystal Briglia, L+A Medical + Wellness Editor Dr. Krystal Briglia of Triada Integrative Medicine + Wellness is a board-certified nurse practitioner specializing in aesthetic dermatology, integrative medicine, and wellness. Journal of Dermatological Science. Journal of the American Academy of Dermatology. Dermatologic Therapy.

Chemical Peels 52

Chemical Peels Vitamin C Hyperpigmentation Microneedling 52

The Dermatology Digest

APRIL 11, 2025

anhydrous gel is showing promise in the treatment of microcystic lymphatic malformations (microcystic LMs), according to a presentation at the 15th World Congress of Pediatric Dermatology in Buenos Aires, Argentina. Food and Drug Administration (FDA)-approved therapies for microcystic LMs. Palvella Therapeutics, Inc. There are no U.S.

Therapy 36

Therapy Dermatology Office Clinic 36

Dermatology Times

NOVEMBER 8, 2024

APPs found that patients on systemic therapies for AD experience fewer issues with adherence compared to those using topicals only.

Therapy 77

Therapy 77

Dermatology Times

FEBRUARY 20, 2024

IV antibiotics should play a complementary role in the management of HS as new immunomodulator therapies are developed, researchers concluded.

Therapy 78

Therapy Management 78

Dermatology Times

NOVEMBER 29, 2024

Hawkes highlighted how second-generation TYK2 inhibitors improve upon earlier oral therapies with greater efficacy and selectivity.

Therapy 74

Therapy 74

The Dermatology Digest

MARCH 7, 2024

More Conference Coverage Welcome to the Golden Age of Pediatric Dermatology Elizabeth Swanson, MD Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. Watch Now SOCS Turns 20!

Dermatology 68

Dermatology Dermatitis Therapy 68

Dermatology Times

JULY 17, 2024

Ben Lockshin, MD, FAAD, shared his insights on the latest advancements in oral options for psoriasis therapies.

Therapy 73

Therapy 73

Dermatology Times

JANUARY 16, 2024

This article will highlight recently approved psoriasis therapies that will shape the 2024 treatment landscape and provide some exciting updates in the psoriasis management market this coming year and beyond.

Therapy 74

Therapy Marketing Management Treatments 74

Dermatology Times

NOVEMBER 10, 2024

At Elevate-Derm West, Murase shared promising results in treating severe itch with emerging therapies, offering hope for patients with few options.

Therapy 78

Therapy 78

Dermatology Times

JULY 12, 2024

Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.

Dermatology 78

Dermatology Education Therapy Treatments 78

Dermatology Times

FEBRUARY 7, 2024

For now, we can learn about the various new innovations and therapies for skin disease at the AAD annual meeting—and continue to strive to improve our patients’ lives here on Earth. Star Trek may call space “the final frontier,” but it’s really the next exciting frontier for humans.

Dermatology 78

Dermatology Innovations Therapy 78

Dermatology Times

FEBRUARY 10, 2025

Review emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.

Therapy 73

Therapy Clinic Treatments 73

The Dermatology Digest

APRIL 22, 2025

dermatology providers agree that moderate-to-severe chronic hand eczema (CHE) has a strong impact on patients work and home life, according to the second phase of the survey sponsored by LEO Pharma Inc. Unmet Needs To date, there are no topical therapies approved by the U.S. Ninety-five percent of U.S. See Part 1 of the survey here.)

Eczema 36

Eczema Dermatology Therapy Office 36

The Dermatology Digest

FEBRUARY 20, 2025

The post Beyond the Headlines: Is Phage Therapy the Next Frontier in Acne Treatment? appeared first on The Dermatology Digest.

Therapy 57

Therapy Treatments Dermatology 57

US Dermatologt Partners

MARCH 3, 2025

Dermatology Partners Fort Worth , While rosacea is a chronic condition with no known cure, there are numerous effective treatments and strategies for managing symptoms. Common symptoms of rosacea that may indicate a need of dermatologic diagnosis and treatment include: Persistent redness in the central facial zone.

Rosacea 45

Rosacea Management Medical Treatments 45

Dermatology Times

FEBRUARY 18, 2025

Jonathan Zalevsky, PhD, discusses the unmet needs in atopic dermatitis treatment, the potential of Rezpeg, and the importance of novel therapies.

Dermatology 68

Dermatology Dermatitis Therapy Treatments 68

Dermatology Times

NOVEMBER 3, 2023

Polyphenols, found in certain foods, have antioxidant and anti-inflammatory properties may help modulate immune responses, offering potential adjunctive therapy for atopic dermatitis, psoriasis, and chronic urticaria.

Dermatology 74

Dermatology Dermatitis Therapy 74

Dermatology Times

JUNE 11, 2024

Jonathan Silverberg, MD, PhD, MPH, and Melinda Gooderham, MSc, MD, FRCPC, debated which patients are a contender for systemic therapy.

Therapy 74

Therapy 74